Literature DB >> 20981866

A simple method for large-scale generation of dopamine neurons from human embryonic stem cells.

Asuka Morizane1, Vladimer Darsalia, M Oktar Guloglu, Tord Hjalt, Manolo Carta, Jia-Yi Li, Patrik Brundin.   

Abstract

Dopamine (DA) neurons derived from human embryonic stem cells (hESCs) are potentially valuable in drug screening and as a possible source of donor tissue for transplantation in Parkinson's disease. However, existing culture protocols that promote the differentiation of DA neurons from hESCs are complex, involving multiple steps and having unreliable results between cultures. Here we report a simple and highly reproducible culture protocol that induces expandable DA neuron progenitors from hESCs in attached cultures. We found that the hESC-derived neuronal progenitors retain their full capacity to generate DA neurons after repeated passaging in the presence of basic fibroblast growth factor (bFGF) and medium conditioned with PA6 stromal cells. Using immunocytochemistry and RT-PCR, we found that the differentiated DA neurons exhibit a midbrain phenotype and express, e.g., Aldh1a, Ptx3, Nurr1, and Lmx1a. Using HPLC, we monitored their production of DA. We then demonstrated that the expanded progenitors are possible to cryopreserve without loosing the dopaminergic phenotype. With our protocol, we obtained large and homogeneous populations of dopaminergic progenitors and neurons. We conclude that our protocol can be used to generate human DA neurons suitable for the study of disease mechanisms, toxicology, drug screening, and intracerebral transplantation.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20981866     DOI: 10.1002/jnr.22515

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  12 in total

Review 1.  Modulation of dopaminergic neuronal differentiation from sympathoadrenal progenitors.

Authors:  Vladimir Vukicevic; Maria F Rubin de Celis; Gabriela Diaz-Valencia; Stefan R Bornstein; Monika Ehrhart-Bornstein
Journal:  J Mol Neurosci       Date:  2012-03-25       Impact factor: 3.444

Review 2.  Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects.

Authors:  Kai-C Sonntag; Bin Song; Nayeon Lee; Jin Hyuk Jung; Young Cha; Pierre Leblanc; Carolyn Neff; Sek Won Kong; Bob S Carter; Jeffrey Schweitzer; Kwang-Soo Kim
Journal:  Prog Neurobiol       Date:  2018-04-11       Impact factor: 11.685

Review 3.  Stem cell technology for neurodegenerative diseases.

Authors:  J Simon Lunn; Stacey A Sakowski; Junguk Hur; Eva L Feldman
Journal:  Ann Neurol       Date:  2011-09       Impact factor: 10.422

4.  Prevention of the degeneration of human dopaminergic neurons in an astrocyte co-culture system allowing endogenous drug metabolism.

Authors:  Liudmila Efremova; Stefan Schildknecht; Martina Adam; Regina Pape; Simon Gutbier; Benjamin Hanf; Alexander Bürkle; Marcel Leist
Journal:  Br J Pharmacol       Date:  2015-06-26       Impact factor: 8.739

5.  Specification of midbrain dopamine neurons from primate pluripotent stem cells.

Authors:  Jiajie Xi; Yan Liu; Huisheng Liu; Hong Chen; Marina E Emborg; Su-Chun Zhang
Journal:  Stem Cells       Date:  2012-08       Impact factor: 6.277

6.  Drug discovery in Parkinson's disease-Update and developments in the use of cellular models.

Authors:  Gaia Skibinski; Steven Finkbeiner
Journal:  Int J High Throughput Screen       Date:  2011-06

7.  On the Road from Phenotypic Plasticity to Stem Cell Therapy.

Authors:  Lorraine Iacovitti
Journal:  J Neurosci       Date:  2021-05-06       Impact factor: 6.167

8.  Tooth engineering: searching for dental mesenchymal cells sources.

Authors:  Laetitia Keller; Sabine Kuchler-Bopp; Soledad Acuña Mendoza; Anne Poliard; Hervé Lesot
Journal:  Front Physiol       Date:  2011-03-04       Impact factor: 4.566

9.  Baculovirus as an ideal radionuclide reporter gene vector: a new strategy for monitoring the fate of human stem cells in vivo.

Authors:  Yu Pan; Shuai Liu; Haifei Wu; Jing Lv; Xiaoqian Xu; Yifan Zhang
Journal:  PLoS One       Date:  2013-04-15       Impact factor: 3.240

10.  Engraftment of mouse embryonic stem cells differentiated by default leads to neuroprotection, behaviour revival and astrogliosis in parkinsonian rats.

Authors:  Debasmita Tripathy; Reena Haobam; Ranju Nair; Kochupurackal P Mohanakumar
Journal:  PLoS One       Date:  2013-09-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.